A CLINICAL CASE REPORT: DIAGNOSIS OF UNILATERAL ANOPHTHALMIA WITH CONTRALATERAL MICROPHTHALMIA CAUSED BY A HETEROZYGOUS SOX2 GENE VARIANT

Kim Hue Nguyen1, Thu Hang Nguyen1, , Hai Bang Ha1, Tri Toa Nguyen1, Duc Truong Nguyen1
1 Bệnh viện A Thái Nguyên

Main Article Content

Abstract

Disorders associated with SOX2 variants, also known as SOX2 gene variant-related eye disorders or SOX2-related malformations, are rare genetic conditions characterized by the absence of one or both eyes (anophthalmia) or abnormally small eyes (microphthalmia). The estimated incidence of anophthalmia at birth is approximately 3 per 100,000 live births, and microphthalmia is approximately 14 per 100,000 live births. However, combined evidence suggests that the incidence of these malformations may be as high as 30 per 100,000 individuals. This is an autosomal dominant genetic disorder, with the majority of cases being de novo. We report a case of a heterozygous SOX2 gene variant detected by next-generation sequencing and validated by direct Sanger sequencing. This case report contributes to expanding our understanding of the pathogenesis and clinical significance of the SOX2 gene variant, providing useful evidence for a broader understanding of disease etiology and offering a scientific basis for obstetricians, geneticists, and prenatal diagnosticians in the early detection, diagnosis, treatment, and counseling of genetic abnormalities in fetuses.

Article Details

References

1. Goyal S, et al. Genetic and environmental factors contributing to anophthalmia and microphthalmia: Current understanding and future directions. World J Clin Pediatr. 2025; 14(2):101982. DOI: 10.5409/wjcp.v14.i2.101982.
2. Verma AS, Fitzpatrick DR. Anophthalmia and microphthalmia. Orphanet J Rare Dis. 2007; 2:47. Published November 26, 2007. DOI: 10.1186/1750-1172-2-47.
3. MedlinePlus Genetics. SOX2 gene. MedlinePlus website. Accessed 2025. https://medlineplus.gov/genetics/gene/SOX2.
4. Dash S, Wong E, et al. The master transcription factor SOX2, mutated in anophthalmia/microphthalmia, is post-transcriptionally regulated by the conserved RNA-binding protein RBM24 in vertebrate eye development. Hum Mol Genet. 2019; 29(4):591-604. DOI: 10.1093/hmg/ddz278.
5. Lin ZB, Li J, Ye L, et al. Novel SOX2 mutation in autosomal dominant cataract- microcornea syndrome. BMC Ophthalmol. 2022; 22:70. DOI:10.1186/s12886-022-02291-4.
6. Ragge NK, et al. SOX2 mutations cause anophthalmia–esophageal–genital (AEG) syndrome. Hum Mol Genet. 2005; 14(9):1215-1223. DOI:10.1093/hmg/ddi132.
7. National Center for Biotechnology Information. VCV000986773.4 – SOX2 NM_003106.4 (SOX2) c.402del. ClinVar. Accessed May 5, 2020. https://www. ncbi.nlm.nih.gov/clinvar/variation/986773/